Industry: Pharmaceuticals, Biotechnology
VectorLogics, Inc., a Delaware corporation, is a privately-held biotechnology firm based in Birmingham, Alabama. The Company was founded in 1998 by David T. Curiel, MD, PhD. VLI is focused on developing products for the treatment of cancer and liver diseases using attenuated viral delivery systems. The cancer products are highly-selective (recognizing cancer cells – avoiding normal cells) and highly-specific (active in cancer cells – inactive in normal cells). Such products should, in the words of the American Association for Cancer Research (AACR), be “radically cleaner, more precise therapies.” The first product candidate that VLI has under development is an oncolytic virotherapeutic for the treatment of ovarian and brain ( www.vectorlogics.com )
VectorLogics , Inc.
550 11Th Street South, CRC 187
Birmingham, Alabama 35294
USA
Tel: (205) 933-8378
Fax: (205) 933-5836